ArticleTranslational stroke research2026
Direct Versus Indirect Bypass in Early-Stage Moyamoya (Suzuki I-III): A Propensity Score-Weighted Study.
Article in Translational stroke research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
48 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Moyamoya angiopathy (MMA) lacks stage-specific comparative evidence for surgical strategy. Because many studies mix Suzuki grades, potential technique effects may be obscured. We compared direct revascularization (DR) with indirect revascularization (IR) in a stage-restricted cohort (Suzuki I-III), using propensity score weighting (PSW). We conducted a multicenter retrospective cohort study across 13 academic centers. Adults with confirmed MMA (Suzuki I-III) who underwent DR or IR were included. Patients < 16 years and combined procedures were excluded. Outcomes were symptomatic stroke, overall perioperative stroke, intraoperative complications, discharge NIHSS/mRS, length of stay, and follow-up stroke. PSW used Covariate Balancing Propensity Scores (CBPS) with absolute standardized mean difference (ASMD) diagnostics. Group differences were modeled with logistic/linear regression, and stroke-free survival was compared by Kaplan-Meier/log-rank. We analyzed 208 hemispheres (IR = 104; DR = 104). Baseline demographics and comorbidities were similar. Unadjusted analyses showed no significant differences in overall perioperative stroke (10.5% IR vs. 8.6% DR; p=.63), symptomatic perioperative stroke, intraoperative complications, discharge NIHSS/mRS, length of stay, or follow-up stroke (8.6% IR vs. 5.8% DR; p=.43). Stroke-free survival did not differ (log-rank p=.40). After PSW, findings remained unchanged across endpoints (e.g., all perioperative stroke OR 1.82; 95% CI, 0.61 to 5.45; p=.27). In adults with MMA at Suzuki I-III, no significant between-group differences were detected between DR and IR in the studied clinical outcomes. Technique selection can be individualized to anatomy, hemodynamics, and center expertise. Prospective, stage-stratified studies with standardized angiographic and hemodynamic endpoints are warranted.
Indexed as
Identifiers
42138779What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.